by chuck_ltd | 16 Mar, 2016 | CHCUK News & Articles, Digital Health Technology, News, Patient Centricity, Pragmatic Trials, Real Word Evidence, Virtual Clinical Research
Davis, CA. – March 07, 2016 – Mytrus, a pioneer in innovative technologies for improving patients’ participation in clinical trials, has announced that its Enroll® and Engage™ technology infrastructure will support the ADAPTABLE (Aspirin Dosing: A...
by chuck_ltd | 16 Feb, 2016 | CHCUK News & Articles, Patient Centricity
FasterCures, a DC-based center of the Milken Institute, is driven by a singular goal – to save lives by speeding up and improving the medical research system. Consider that there are more than 10,000 known diseases affecting our world today; we have viable treatments...
by chuck_ltd | 26 Jan, 2016 | CHCUK News & Articles, News, Patient Centricity
I came across a good article in HC Hotline written by Victoria Bruce, which discusses chronic diseases, such as Irritable Bowel Syndrome (IBS) and Crohn’s Disease, which can greatly impact the workplace but which the workplace culture can ease and ameliorate. This,...
by chuck_ltd | 7 Jan, 2016 | CHCUK News & Articles, News, Patient Centricity
This whitepaper from Eye for Pharma, draws on case studies and expert insight to provide actionable recommendations for embedding patient-centred focus into the culture of pharmaceutical organisations. Evidence is provided that organisations can be patient-centred by...
by chuck_ltd | 7 Jan, 2016 | CHCUK News & Articles, News, Patient Centricity
Introduction The Stockholm Administrative Court of Appeal recently considered whether financial aspects can be assessed when determining whether there are special requirements for granting a named patient permission. The court dismissed arguments that high prices and...
by chuck_ltd | 30 Dec, 2015 | CHCUK News & Articles, News, Patient Centricity
As part of FDA’s commitments under the Prescription Drug User Fee Act reauthorization of 2012, FDA has taken several steps to inform assessment of benefit-risk in CDER’s regulatory decisions concerning new drugs. The Patient-Focused Drug Development (PFDD) initiative...
